JuHyun Bae | Cancer immunotherapy | Best Researcher Award

Best Researcher Award

JuHyun Bae
Affiliation Kyungpook National University School of Medicine
Country South Korea
Scopus ID 57225046295
Documents 15
Citations 375
h-index 10
Subject Area Cancer Immunotherapy
Event Biotechnology Scientist Awards
ORCID 0000-0002-2025-3772

JuHyun Bae
Kyungpook National University School of Medicine

JuHyun Bae, a researcher affiliated with Kyungpook National University School of Medicine, South Korea. This publication-style profile summarizes publicly available scholarly information, including research metrics, publication output, citation performance, scientific contributions, and subject expertise in Cancer Immunotherapy. The article follows a neutral, Wikipedia-inspired presentation suitable for academic recognition and professional reference.[1]

Abstract

JuHyun Bae has established a research profile focused on Cancer Immunotherapy through peer-reviewed scientific publications indexed in international bibliographic databases. Current publicly available metrics indicate 15 indexed publications, 375 citations, and an h-index of 10, reflecting consistent scientific productivity and measurable scholarly influence. This article summarizes the research profile using an objective academic format appropriate for institutional review and research recognition.[1]

Keywords

Cancer Immunotherapy, Oncology, Immunology, Precision Medicine, Translational Medicine, Biomedical Research, Scientific Publications, Citation Analysis, Biotechnology Scientist Awards, Best Researcher Award.

Introduction

Academic excellence is evaluated through a combination of research quality, publication output, citation performance, innovation, and contributions to scientific advancement. Bibliometric databases such as Scopus provide standardized indicators that assist universities, research organizations, funding agencies, and award committees in conducting objective evaluations while complementing expert peer review.[2]

Research Profile

JuHyun Bae is affiliated with Kyungpook National University School of Medicine in South Korea. The available scholarly record demonstrates active research in Cancer Immunotherapy with publications appearing in internationally indexed journals. The research portfolio contributes to ongoing investigations in biomedical science, translational medicine, and cancer-related therapeutic strategies.[1]

Research Contributions

  • Published peer-reviewed research in Cancer Immunotherapy and biomedical sciences.
  • Supported advances in translational oncology research.
  • Contributed to internationally indexed scientific literature.
  • Participated in collaborative biomedical research activities.
  • Enhanced scientific knowledge through evidence-based medical research.

Publications

The researcher’s Scopus profile records 15 indexed publications. These scholarly works contribute to Cancer Immunotherapy and related biomedical disciplines. Many scientific articles include Digital Object Identifiers (DOIs), providing permanent identification and reliable access to published research while supporting accurate scholarly citation.[3]

  • Peer-reviewed journal publications indexed in Scopus.
  • Research articles in oncology, immunology, and translational medicine.

Research Impact

Bibliometric indicators report 15 indexed documents, 375 citations, and an h-index of 10. These metrics demonstrate measurable scholarly visibility and research influence within the biomedical sciences. Quantitative indicators should be interpreted together with publication quality, originality, scientific rigor, collaborative engagement, and broader contributions to medical research.[1]

Award Suitability

Based on publicly available academic indicators, JuHyun Bae demonstrates characteristics commonly considered during evaluations for recognition programs such as the Biotechnology Scientist Awards. Consideration may include publication quality, research significance, citation influence, innovation, ethical research conduct, collaborative achievements, and contributions to Cancer Immunotherapy. Final award decisions remain subject to independent peer review and committee evaluation.[2]

Conclusion

This academic profile presents a structured overview of JuHyun Bae’s scholarly achievements using publicly available bibliographic information. The article follows a neutral encyclopedia-style presentation that emphasizes research productivity, publication performance, scientific impact, and professional contributions, making it suitable for academic reference, institutional evaluation, and research recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: JuHyun Bae, Author ID 57225046295. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57225046295
  2. Systematic discovery of immunomodulatory plant-derived nanoparticles reveals RNA-mediated macrophage reprogramming.
    https://www.sciencedirect.com/science/article/pii/S2452199X26003701?via%3Dihub
  3. Determination of extracellular vesicle size and surface charge density via precise measurements of Brownian motion, electrophoretic velocity, and applied electric field in a single platform.
    https://www.sciencedirect.com/science/article/abs/pii/S0925400526001486?via%3Dihub

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Prof. Dr. Yanchuan Li | Nanjing Medical University | China

Dr. Yanchuan Li (李砚川), born in 1985 in Pingxiang, Jiangxi, is a distinguished cancer immunology researcher. He earned his Ph.D. in Biochemistry and Molecular Biology from Peking Union Medical College (Tsinghua University School of Medicine) in 2016 under the mentorship of Academician Linfang Wang and Prof. Shao-Cong Sun. Currently, he is a Professor and Ph.D. advisor at Nanjing Medical University, focusing on tumor and immune research. His expertise spans lymphocyte receptor signaling, CAR-NKT cell therapy, and molecular immunology. His groundbreaking research has been published in Cell Research, Blood, JEM, and Nature Communications. He also serves as a reviewer for top journals like Cellular & Molecular Immunology, Nucleic Acids Research, and Molecular Therapy. πŸŽ“πŸ”

Professional Profile:

Google Scholar

Suitability for Best Researcher Award

Dr. Yanchuan Li is a highly suitable candidate for a Best Researcher Award due to his exceptional contributions to cancer immunology and molecular immunology. Dr. Li’s expertise in lymphocyte receptor signaling, CAR-NKT cell therapy, and tumor immunology has significantly advanced the understanding of immune regulation in cancer. His research impacts both fundamental immunological mechanisms and translational applications, making him a distinguished figure in the field.

Education & Experience πŸ“šπŸ‘¨β€πŸ”¬

  • 2012-2016 πŸŽ“ Ph.D. in Biochemistry & Molecular Biology – Peking Union Medical College (Tsinghua University School of Medicine)
  • 2014-2016 🌎 Visiting Ph.D. Scholar – MD Anderson Cancer Center, USA (CSC Scholarship)
  • 2016-2021 πŸ§ͺ Postdoctoral Research Fellow – MD Anderson Cancer Center, USA
  • 2021-2022 πŸ₯ Research Scientist – MD Anderson Cancer Center, USA
  • 2022-2023 πŸ”¬ Research Associate – Baylor College of Medicine, USA
  • 2023-Present πŸŽ“ Professor & Ph.D. Supervisor – Nanjing Medical University

Professional Development πŸ”¬πŸ“ˆ

Dr. Li’s research bridges fundamental tumor immunology and translational medicine, employing cell culture, gene manipulation, proteomics, and multi-omics approaches. His work utilizes CRISPR/Cas9 screening, single-cell analysis, and knockout mouse models to uncover key immune signaling mechanisms. His significant contributions to B cell function, CAR-NKT therapy, and immune regulation in major diseases are paving the way for innovative cancer treatments. He has played a key role in developing CAR-NKT cell therapies, including a clinical trial for relapsed neuroblastoma. His dedication to scientific excellence and interdisciplinary collaboration is shaping the future of cancer immunotherapy. πŸ₯πŸ§¬πŸ’‘

Research Focus πŸ”πŸ¦ 

Dr. Li’s research covers tumor immunology and translational medicine, with key interests in:
1️⃣ B Cell Function & Autoimmunity – Exploring B cell activation in diseases like SLE & B cell leukemia. πŸ”¬πŸ¦ 
2️⃣ CAR-NKT Cell Therapy – Engineering NKT cells for safer and more effective cancer immunotherapy. πŸŽ―πŸ’‰
3️⃣ Molecular Mechanisms of Major Diseases – Utilizing multi-omics & disease models to investigate cancer progression, autoimmune disorders, and drug response. πŸ§ͺπŸ“Š
4️⃣ Advanced Immuno-Analytical Techniques – Developing single-cell spatial transcriptomics, CRISPR-based screens, and novel proteomics to revolutionize cancer research. πŸ”πŸ”¬

Awards & Honors πŸ†πŸŽ–οΈ

  • πŸ… Outstanding Ph.D. Graduate – Peking Union Medical College, 2016
  • πŸ… Outstanding Ph.D. Graduate – Beijing Municipality, 2016
  • ⭐ Annual Excellence Award – Nanjing Medical University, 2023
  • πŸ’° West Taihu Cell Therapy Foundation Grant – 500,000 CNY

Publication Top Notes:Β 

πŸ“’Β Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages – Cited by 97 πŸ”¬
🧬Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results – Cited by 87 πŸ₯
🦠 TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis – Cited by 78 🧫
πŸ›‘Cell intrinsic role of NF-ΞΊB-inducing kinase in regulating T cell-mediated immune and autoimmune responses – Cited by 67 πŸ‹οΈ
🧩 Β Preventing abnormal NF-ΞΊB activation and autoimmunity by Otub1-mediated p100 stabilization – Cited by 44 πŸ—
🦠 NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis – Cited by 44 🦠
πŸ”₯ Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination – Cited by 43 πŸš€
🧠 Microglia promote autoimmune inflammation via the noncanonical NF-ΞΊB pathway – Cited by 42 🧠
🌿 Β Protective effect of melatonin on cigarette smoke‐induced restenosis in rat carotid arteries after balloon injury – Cited by 40 πŸŒ™
🦠 Intestinal epithelial TBK1 prevents differentiation of T-helper 17 cells and tumorigenesis in mice – Cited by 30 πŸ₯